The Stochastic Oscillator for IMRA moved out of overbought territory on July 15, 2025. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 22 similar instances where the indicator exited the overbought zone. In of the 22 cases the stock moved lower. This puts the odds of a downward move at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for IMRA entered a downward trend on June 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Momentum Indicator moved above the 0 level on July 02, 2025. You may want to consider a long position or call options on IMRA as a result. In of 51 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for IMRA just turned positive on July 02, 2025. Looking at past instances where IMRA's MACD turned positive, the stock continued to rise in of 24 cases over the following month. The odds of a continued upward trend are .
IMRA moved above its 50-day moving average on July 17, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRA advanced for three days, in of 134 cases, the price rose further within the following month. The odds of a continued upward trend are .
a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies
Category Unknown